Today’s issue of WorkCompRecap features the DEA’s recent announcement that a recent intelligence report has found that hundreds of thousands of counterfeit prescription pills, many containing deadly amounts of fentanyl and fentanyl-related compounds, have made their way into the U.S. drug market.
Other findings included that since 2014 law enforcement agencies have been seizing new counterfeit prescription opioid pills containing fentanyl or related compounds. A seizure in Ohio earlier this year turned up pills that appeared to be oxycodone, but actually contained an unscheduled synthetic opioid that had not been studied for human use. The DEA noted that the rise of counterfeit pills in the illicit drug market will likely result in more opioid-dependent individuals, overdoses, and deaths.
Find out more (including a link to the free report!) by clicking here!